Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy - a podcast by ReachMD

CME credits: 0.50

Valid until: 30-04-2022

Claim your CME credit at https://reachmd.com/programs/cme/type-1-diabetes-the-role-of-anti-cd3-targeted-therapy/12503/

Experts in the immunopathology of type 1 diabetes discuss the epidemiology, non-genetic and genetic risk factors, and progression from preclinical to clinical stages of this disease. The discussion will emphasize the breakdown of immune tolerance that precedes type 1 diabetes and the subsequent pathogenetic role of islet autoantibodies responsible for its clinical manifestations.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD